MRP2 > OATP2B1 > BCRP,在正常人腸道表達(dá)量順序?yàn)锽CRP > MDR1 > MRP2 > OATP2B1;轉(zhuǎn)運(yùn)蛋白活力評(píng)價(jià)表明,各藥物轉(zhuǎn)運(yùn)蛋白的活力測(cè)試結(jié)果均為陽(yáng)性,驗(yàn)證了基因的表達(dá)水平結(jié)果。結(jié)論 Caco-2細(xì)胞中表達(dá)正常人體腸道表達(dá)的部分藥物轉(zhuǎn)運(yùn)蛋白(MDR1、MRP2、BCRP和OATP2B1),表達(dá)水平與正常人體腸道中大致相當(dāng),但也存在一定差異。;Objective To study the mRNA expression and transport activity of drug transporters in Caco-2 cells, and compare the differences of the expression of drug transporters between Caco-2 cells and human normal intestinal. Method Establishing a method for the determination of mRNA expression of drug transporter by qRT-PCR method to determine the expression levels of human intestinal related transport proteins MDR1, BCRP, MRP2, OATP1A2, OATP2B1, and PEPT1 in Caco-2 cells; Caco-2 was then seeded in Transwell plates for 21 days and administered with different drug transporter substrates and inhibitors to assess the transporter activity of the relevant transporter in Caco-2 cells. Results The qRT-PCR results indicated that MDR1, MRP2, BCRP, and OATP2B1 were relatively higher expressed in Caco-2 cells. The relative expression levels of various drug transporters were as follows:MDR1 > MRP2 > OATP2B1 > BCRP, the expression level of intestinal tract in normal subjects was BCRP > MDR1 > MRP2 > OATP2B1. Drug transporter activity assessment showed that all drug transporter activity test results were positive, validating the expression level of the previous drug transporter gene. Conclusions The expression levels of many drug transporters (MDR1, MRP2, BCRP and OATP2B1) originated from normal human intestinal tract expressed in Caco-2 cells were roughly equivalent to those expressed in the normal human intestinal tract, but there were also some differences between them."/>

醉酒后少妇被疯狂内射视频,一本色道久久综合一,在线天堂新版资源www在线下载,中文字幕乱人伦高清视频,中字幕视频在线永久在线观看免费

首頁(yè) > 過刊瀏覽>2018年第41卷第6期 >2018,41(6):980-985. DOI:10.7501/j.issn.1674-6376.2018.06.008
上一篇 | 下一篇

Caco-2細(xì)胞中藥物轉(zhuǎn)運(yùn)蛋白的mRNA表達(dá)及活力評(píng)價(jià)

Expression of drug transporters mRNA in Caco-2 cells and its viability evaluation

發(fā)布日期:2018-06-05
您是第位訪問者
藥物評(píng)價(jià)研究 ® 2025 版權(quán)所有
技術(shù)支持:北京勤云科技發(fā)展有限公司
津備案:津ICP備13000267號(hào) 互聯(lián)網(wǎng)藥品信息服務(wù)資格證書編號(hào):(津)-非經(jīng)營(yíng)性-2015-0031